Literature DB >> 6798843

Central neurofibromatosis with bilateral acoustic neuroma.

R Eldridge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6798843

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  19 in total

1.  The neurosurgical aspects of neurofibromatosis 2: diagnosis and management.

Authors:  M Turgut; S Palaoğlu; O E Ozcan
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

Review 2.  Genomic imprinting: review and relevance to human diseases.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

3.  Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.

Authors:  Rong Rong; Xiaoling Tang; David H Gutmann; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-14       Impact factor: 11.205

4.  Detection of spontaneous schwannomas by MRI in a transgenic murine model of neurofibromatosis type 2.

Authors:  S M Messerli; Y Tang; M Giovannini; R Bronson; R Weissleder; X O Breakefield
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

5.  Listeria monocytogenes exploits ERM protein functions to efficiently spread from cell to cell.

Authors:  Sascha Pust; Helen Morrison; Jürgen Wehland; Antonio S Sechi; Peter Herrlich
Journal:  EMBO J       Date:  2005-02-24       Impact factor: 11.598

6.  Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein.

Authors:  M Giovannini; E Robanus-Maandag; M Niwa-Kawakita; M van der Valk; J M Woodruff; L Goutebroze; P Mérel; A Berns; G Thomas
Journal:  Genes Dev       Date:  1999-04-15       Impact factor: 11.361

7.  The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

Authors:  H Morrison; L S Sherman; J Legg; F Banine; C Isacke; C A Haipek; D H Gutmann; H Ponta; P Herrlich
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

8.  Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.

Authors:  Abraham Jacob; Janet Oblinger; Matthew L Bush; Victoria Brendel; Griffin Santarelli; Abhik R Chaudhury; Samuel Kulp; Krista M D La Perle; Ching-Shih Chen; Long-Sheng Chang; D Bradley Welling
Journal:  Laryngoscope       Date:  2011-11-22       Impact factor: 3.325

Review 9.  Clinical and genetic patterns of neurofibromatosis 1 and 2.

Authors:  N K Ragge
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

10.  Molecular genetic approach to human meningioma: loss of genes on chromosome 22.

Authors:  B R Seizinger; S de la Monte; L Atkins; J F Gusella; R L Martuza
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.